These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22960857)

  • 1. Curtailing overexpression of E2F3 in breast cancer using siRNA (E2F3)-based gene silencing.
    Vimala K; Sundarraj S; Sujitha MV; Kannan S
    Arch Med Res; 2012 Aug; 43(6):415-22. PubMed ID: 22960857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear overexpression of the E2F3 transcription factor in human lung cancer.
    Cooper CS; Nicholson AG; Foster C; Dodson A; Edwards S; Fletcher A; Roe T; Clark J; Joshi A; Norman A; Feber A; Lin D; Gao Y; Shipley J; Cheng SJ
    Lung Cancer; 2006 Nov; 54(2):155-62. PubMed ID: 16938365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
    Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridge-1 is expressed in human breast carcinomas: silencing of Bridge-1 decreases Smad2, Smad3 and Smad4 expression in MCF-7 cells, a human breast cancer cell line.
    Banz-Jansen C; Münchow B; Diedrich K; Finas D
    Arch Gynecol Obstet; 2011 Dec; 284(6):1543-9. PubMed ID: 21448710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification and overexpression of E2F3 in human bladder cancer.
    Feber A; Clark J; Goodwin G; Dodson AR; Smith PH; Fletcher A; Edwards S; Flohr P; Falconer A; Roe T; Kovacs G; Dennis N; Fisher C; Wooster R; Huddart R; Foster CS; Cooper CS
    Oncogene; 2004 Feb; 23(8):1627-30. PubMed ID: 14716298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
    Liang CY; Ma P; Liu XL
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.
    Chua PJ; Lee EH; Yu Y; Yip GW; Tan PH; Bay BH
    Int J Oncol; 2010 Feb; 36(2):359-64. PubMed ID: 20043069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
    Nagahara H; Mimori K; Utsunomiya T; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6800-6. PubMed ID: 16203767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth inhibition of breast cancer cells in vitro and in vivo by siRNA targeting signal transducers and activators of transcription 3].
    Yang Z; Yan L; Zhang F; Yan QH; Song WQ; Wang FA; Cai JH
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):819-24. PubMed ID: 21223686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sox17 regulates proliferation and cell cycle during gastric cancer progression.
    Ye YW; Wu JH; Wang CM; Zhou Y; Du CY; Zheng BQ; Cao X; Zhou XY; Sun MH; Shi YQ
    Cancer Lett; 2011 Aug; 307(2):124-31. PubMed ID: 21514720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis.
    Lee M; Oprea-Ilies G; Saavedra HI
    Oncotarget; 2015 Nov; 6(35):37316-34. PubMed ID: 26512919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer.
    Reimer D; Hubalek M; Kiefel H; Riedle S; Skvortsov S; Erdel M; Hofstetter G; Concin N; Fiegl H; Müller-Holzner E; Marth C; Altevogt P; Zeimet AG
    Oncogene; 2011 Sep; 30(38):4038-49. PubMed ID: 21516127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of breast cancer cell line MCF-7 by siRNA silencing of Wilms tumor 1 gene.
    Navakanit R; Graidist P; Leeanansaksiri W; Dechsukum C
    J Med Assoc Thai; 2007 Nov; 90(11):2416-21. PubMed ID: 18181329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
    Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
    Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer.
    Liu TG; Yin JQ; Shang BY; Min Z; He HW; Jiang JM; Chen F; Zhen YS; Shao RG
    Cancer Gene Ther; 2004 Nov; 11(11):748-56. PubMed ID: 15375377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.